Investing.com - Taysha Gene reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Taysha Gene announced earnings per share of $-0.64 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.83 on revenue of $0.
Taysha Gene 's are down 27% and is trading at $2.06 , still down 87.19% from its 52 week high of $16.08 set on Wednesday, November 10, 2021.
Taysha Gene shares gained 3.00% to trade at $2.06 in intra-day trade the report.
Taysha Gene follows other major Healthcare sector earnings this month
Taysha Gene's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar